|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175.22 USD | -1.09% |
|
-5.67% | -19.37% |
| 11/06 | British device maker Halma's shares slump on slower annual growth forecast | RE |
| 11/06 | CME Group Enters Licensing Agreement With Morningstar to Offer Derivatives Products | DJ |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.39 | 4.05 | 4.19 | 7.57 | 8.86 | |||||
Return on Total Capital | 9.23 | 5.73 | 5.74 | 10.5 | 12.64 | |||||
Return On Equity % | 14.39 | 5.38 | 11.13 | 25.11 | 26.35 | |||||
Return on Common Equity | 14.39 | 5.38 | 11.13 | 25.11 | 26.35 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 58.9 | 58.34 | 58.62 | 60.63 | 61.03 | |||||
SG&A Margin | 33.32 | 38.46 | 38.24 | 33.77 | 32.57 | |||||
EBITDA Margin % | 22.06 | 16.44 | 16.4 | 22.69 | 24.26 | |||||
EBITA Margin % | 20.36 | 14.54 | 14.77 | 21.33 | 23.14 | |||||
EBIT Margin % | 16.71 | 10.97 | 11.31 | 18.5 | 20.7 | |||||
Income From Continuing Operations Margin % | 11.38 | 3.77 | 6.92 | 16.26 | 15.3 | |||||
Net Income Margin % | 11.38 | 3.77 | 6.92 | 16.26 | 15.3 | |||||
Net Avail. For Common Margin % | 11.38 | 3.77 | 6.92 | 16.26 | 15.3 | |||||
Normalized Net Income Margin | 10.19 | 5.56 | 5.25 | 9.91 | 12.15 | |||||
Levered Free Cash Flow Margin | 20.4 | 12.89 | 9.49 | 21.22 | 18.25 | |||||
Unlevered Free Cash Flow Margin | 20.78 | 13.89 | 11.35 | 22.59 | 19.28 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.59 | 0.59 | 0.65 | 0.69 | |||||
Fixed Assets Turnover | 5.45 | 5.25 | 5.35 | 5.9 | 6.18 | |||||
Receivables Turnover (Average Receivables) | 7.17 | 6.49 | 6.26 | 6.48 | 6.53 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.13 | 0.92 | 0.93 | 1.05 | 0.99 | |||||
Quick Ratio | 1.05 | 0.82 | 0.83 | 0.95 | 0.89 | |||||
Operating Cash Flow to Current Liabilities | 0.57 | 0.34 | 0.36 | 0.61 | 0.56 | |||||
Days Sales Outstanding (Average Receivables) | 50.91 | 56.27 | 58.35 | 56.47 | 55.86 | |||||
Average Days Payable Outstanding | 36.84 | 35.76 | 33.45 | 33.85 | 35.47 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 37.54 | 109.65 | 87.38 | 55.85 | 103.21 | |||||
Total Debt / Total Capital | 27.29 | 52.3 | 46.63 | 35.84 | 50.79 | |||||
LT Debt/Equity | 34.97 | 103.9 | 82.22 | 53.68 | 99.79 | |||||
Long-Term Debt / Total Capital | 25.42 | 49.56 | 43.88 | 34.44 | 49.11 | |||||
Total Liabilities / Total Assets | 50.54 | 65.26 | 60.99 | 54.39 | 65.97 | |||||
EBIT / Interest Expense | 27.31 | 6.82 | 3.8 | 8.43 | 12.66 | |||||
EBITDA / Interest Expense | 41.68 | 12.16 | 6.59 | 11.53 | 16.39 | |||||
(EBITDA - Capex) / Interest Expense | 31.89 | 7.86 | 4.63 | 8.67 | 12.71 | |||||
Total Debt / EBITDA | 1.23 | 3.62 | 2.9 | 1.57 | 1.92 | |||||
Net Debt / EBITDA | -0.03 | 2.48 | 1.93 | 0.61 | 1.12 | |||||
Total Debt / (EBITDA - Capex) | 1.6 | 5.6 | 4.13 | 2.09 | 2.48 | |||||
Net Debt / (EBITDA - Capex) | -0.04 | 3.84 | 2.75 | 0.82 | 1.44 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 22.3 | 10.08 | 8.98 | 11.6 | 7.49 | |||||
Gross Profit, 1 Yr. Growth % | 20.14 | 9.03 | 9.51 | 15.42 | 8.21 | |||||
EBITDA, 1 Yr. Growth % | 14.06 | -17.96 | 12.94 | 54.44 | 14.93 | |||||
EBITA, 1 Yr. Growth % | 14.65 | -21.42 | 15.63 | 61.18 | 16.63 | |||||
EBIT, 1 Yr. Growth % | 16.87 | -27.75 | 19.05 | 82.48 | 20.29 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -13.55 | -63.53 | 100.14 | 162.15 | 1.16 | |||||
Net Income, 1 Yr. Growth % | -13.55 | -63.53 | 100.14 | 162.15 | 1.16 | |||||
Normalized Net Income, 1 Yr. Growth % | 21.44 | -39.89 | 10.45 | 110.75 | 30.36 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -14.09 | -63.15 | 100.61 | 160.79 | 3.38 | |||||
Accounts Receivable, 1 Yr. Growth % | 31.11 | 14.5 | 11.69 | 4.13 | 9.02 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.01 | 21.81 | -4.96 | 7.67 | -2.3 | |||||
Total Assets, 1 Yr. Growth % | 6.18 | 21.38 | -2.05 | 4.28 | 1.16 | |||||
Tangible Book Value, 1 Yr. Growth % | -61.97 | 665.47 | -19.47 | -52.11 | 118.11 | |||||
Common Equity, 1 Yr. Growth % | 11.37 | -14.75 | 10 | 21.9 | -24.51 | |||||
Cash From Operations, 1 Yr. Growth % | 17.07 | -33.81 | 6.25 | 86.98 | -0.32 | |||||
Capital Expenditures, 1 Yr. Growth % | 32.72 | 27.21 | -8.03 | 19.82 | 3.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -1.49 | -30.46 | -17.26 | 149.48 | -7.53 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.58 | -26.41 | -8.41 | 122.06 | -8.28 | |||||
Dividend Per Share, 1 Yr. Growth % | 6.97 | 11.07 | 4.79 | 9.15 | 11.68 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 20.05 | 16.03 | 9.53 | 10.28 | 9.53 | |||||
Gross Profit, 2 Yr. CAGR % | 19.93 | 14.45 | 9.27 | 12.43 | 11.76 | |||||
EBITDA, 2 Yr. CAGR % | 23.38 | 1.11 | -1.96 | 32.07 | 33.23 | |||||
EBITA, 2 Yr. CAGR % | 23.71 | -0.38 | -2.85 | 36.52 | 37.1 | |||||
EBIT, 2 Yr. CAGR % | 22.39 | -2.35 | -5.28 | 47.39 | 48.16 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 12.77 | -43.85 | -14.56 | 129.06 | 62.85 | |||||
Net Income, 2 Yr. CAGR % | 12.77 | -43.85 | -14.56 | 129.06 | 62.85 | |||||
Normalized Net Income, 2 Yr. CAGR % | 25.13 | -8.83 | -17.25 | 52.57 | 65.23 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 12.44 | -43.73 | -14.02 | 128.73 | 64.2 | |||||
Accounts Receivable, 2 Yr. CAGR % | 19.44 | 22.52 | 13.09 | 7.84 | 6.55 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.53 | 13.63 | 7.59 | 1.16 | 2.56 | |||||
Total Assets, 2 Yr. CAGR % | 9.88 | 13.53 | 9.04 | 1.06 | 2.71 | |||||
Tangible Book Value, 2 Yr. CAGR % | -35.74 | 70.62 | 148.28 | -37.9 | 2.21 | |||||
Common Equity, 2 Yr. CAGR % | 14.31 | -2.56 | -3.16 | 15.8 | -4.07 | |||||
Cash From Operations, 2 Yr. CAGR % | 15.99 | -11.97 | -16.14 | 40.95 | 36.52 | |||||
Capital Expenditures, 2 Yr. CAGR % | 12.81 | 29.94 | 8.16 | 4.97 | 11.13 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 17.43 | -15.23 | -23.52 | 43.35 | 49.73 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 17.26 | -12.76 | -17.04 | 42.62 | 42.72 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.99 | 9.21 | 8.07 | 6.95 | 10.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 18.55 | 16.63 | 13.63 | 10.22 | 9.34 | |||||
Gross Profit, 3 Yr. CAGR % | 18.02 | 16.18 | 12.78 | 11.28 | 11 | |||||
EBITDA, 3 Yr. CAGR % | 11.59 | 7.69 | 3.58 | 14.08 | 26.09 | |||||
EBITA, 3 Yr. CAGR % | 13.52 | 6.34 | 3.19 | 15.01 | 29.54 | |||||
EBIT, 3 Yr. CAGR % | 9.59 | 2.67 | 2.33 | 17.86 | 37.74 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 1.84 | -22.59 | -14.23 | 24.15 | 74.44 | |||||
Net Income, 3 Yr. CAGR % | 1.84 | -22.59 | -14.23 | 24.15 | 74.44 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.03 | -2 | -5.1 | 13.01 | 45.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.54 | -22.48 | -14.04 | 24.46 | 75.53 | |||||
Accounts Receivable, 3 Yr. CAGR % | 16.02 | 17.77 | 18.8 | 10.02 | 8.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 30.78 | 9.29 | 7.06 | 7.62 | -0.01 | |||||
Total Assets, 3 Yr. CAGR % | 25.34 | 13.59 | 8.08 | 7.43 | 1.1 | |||||
Tangible Book Value, 3 Yr. CAGR % | -26.79 | 46.76 | 32.84 | 43.46 | -5.6 | |||||
Common Equity, 3 Yr. CAGR % | 14.85 | 3.66 | 1.46 | 4.56 | 0.41 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.64 | -3.79 | -6.28 | 9.56 | 25.57 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.18 | 17.42 | 15.8 | 11.92 | 4.34 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.83 | -1.39 | -16.76 | 13.43 | 23.86 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.35 | 0.39 | -12.16 | 15.19 | 23.1 | |||||
Dividend Per Share, 3 Yr. CAGR % | 8.21 | 8.47 | 7.84 | 8.43 | 8.5 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.3 | 15.46 | 14.86 | 14.05 | 11.97 | |||||
Gross Profit, 5 Yr. CAGR % | 17.11 | 15.76 | 14.44 | 14.66 | 12.37 | |||||
EBITDA, 5 Yr. CAGR % | 10.12 | 5.94 | 4.39 | 15.96 | 14.56 | |||||
EBITA, 5 Yr. CAGR % | 11.56 | 7.05 | 4.95 | 16.5 | 15.61 | |||||
EBIT, 5 Yr. CAGR % | 9.45 | 3.86 | 1.34 | 17.29 | 18.66 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 3.72 | -12.43 | -5.07 | 19.47 | 10.85 | |||||
Net Income, 5 Yr. CAGR % | 3.72 | -12.43 | -5.07 | 19.47 | 10.85 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.18 | 0.81 | -4.34 | 15.32 | 18.87 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 3.65 | -12.4 | -4.99 | 19.51 | 11.36 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.02 | 15.75 | 14.84 | 13.69 | 13.74 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.11 | 21.54 | 20.96 | 5.96 | 5.24 | |||||
Total Assets, 5 Yr. CAGR % | 16.21 | 19.84 | 18.54 | 8.4 | 5.9 | |||||
Tangible Book Value, 5 Yr. CAGR % | 44.71 | 44.57 | 19.32 | 4.04 | 19.62 | |||||
Common Equity, 5 Yr. CAGR % | 15.24 | 8.44 | 7.27 | 8.36 | -0.79 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.05 | 3.55 | 0.1 | 12.09 | 8.94 | |||||
Capital Expenditures, 5 Yr. CAGR % | 10.14 | 14.22 | 9.37 | 12.27 | 13.91 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 17.73 | 6.94 | -0.3 | 13.94 | 5.88 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 18.02 | 8.27 | 3.21 | 14.88 | 6.66 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.96 | 9.13 | 8.24 | 7.94 | 8.86 |
- Stock Market
- Stocks
- MORN Stock
- Financials Morningstar, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















